Cargando…

The effect of statins on average survival in randomised trials, an analysis of end point postponement

OBJECTIVE: To estimate the average postponement of death in statin trials. SETTING: A systematic literature review of all statin trials that presented all-cause survival curves for treated and untreated. INTERVENTION: Statin treatment compared to placebo. PRIMARY OUTCOME MEASURES: The average postpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kristensen, Malene Lopez, Christensen, Palle Mark, Hallas, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593138/ https://www.ncbi.nlm.nih.gov/pubmed/26408281 http://dx.doi.org/10.1136/bmjopen-2014-007118

Ejemplares similares

Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
por: Tudor, Kate, et al.
Publicado: (2020)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023)

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial
por: Svensson, Annemarie Lyng, et al.
Publicado: (2016)

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care
por: Herrett, Emily, et al.
Publicado: (2017)

World's end postponed
Publicado: (2008)

The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol
por: Berg, Selina Kikkenborg, et al.
Publicado: (2016)

Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
por: Garrison, Scott R, et al.
Publicado: (2022)

Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials
por: Zhou, Zhen, et al.
Publicado: (2017)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
por: Mackenzie, Isla S, et al.
Publicado: (2016)

Bedtime versus morning use of antihypertensives in frail continuing care residents (BedMed-Frail): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
por: Garrison, Scott R, et al.
Publicado: (2023)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

The heart & mind trial: intervention with cognitive–behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol
por: Berg, Selina Kikkenborg, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
por: Rorie, David A, et al.
Publicado: (2016)

End of the world postponed until Christmas
Publicado: (2009)

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
por: Jaspers, Nicole E M, et al.
Publicado: (2021)

Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo
por: Palarasah, Yaseelan, et al.
Publicado: (2022)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Time trends in statin utilisation and coronary mortality in Western European countries
por: Vancheri, Federico, et al.
Publicado: (2016)

Statin associated adverse reactions in Latin America: a scoping review
por: Urina-Jassir, Manuel, et al.
Publicado: (2021)

In situ assessment of statins’ effect on autophagic activity in zebrafish larvae cardiomyocytes
por: Zhang, Jie, et al.
Publicado: (2022)

Immediate versus postponed single blastocyst transfer in modified natural cycle frozen embryo transfer (mNC-FET): a study protocol for a multicentre randomised controlled trial
por: Bergenheim, Sara Johanna, et al.
Publicado: (2021)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
por: Adam, Luise, et al.
Publicado: (2023)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study
por: Kouhpeikar, Hamideh, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

C-reactive protein and coronary atheroma regression following statin therapy: A meta-regression of randomized controlled trials
por: Gao, Darui, et al.
Publicado: (2022)

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan
por: Takeda, Yasutaka, et al.
Publicado: (2022)

Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study
por: Simonsen, Jane Angel, et al.
Publicado: (2017)

Image of Statin-Induced Rhabdomyolysis
por: Kim, Min Chul, et al.
Publicado: (2020)

High-density mapping of the average complex interval helps localizing atrial fibrillation drivers and predicts catheter ablation outcomes
por: Squara, Fabien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p8um2kr2vjkk1s011qugsnvkre